The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Lucentis
Australian Public Assessment Report
Device/Product Name
Lucentis
Active ingredients
Ranibizumab
AusPAR Date
Published
Submission Number
PM-2020-04187-1-5
Submission Type
Extension of indications
Decision
Approved